Search Here

More than 2 million people in United States are suffering from chronic Hepatitis C which can cause liver failure and in extreme cases, even death. However, thanks to the work of researchers at Intermountain Medical Center in Murray, there is still some hope left for the patients who are victims of advanced liver disease caused due to chronic infection. Dr. Michael Charlton, director of the Liver Transplantation Program at Intermountain Medical Center Researchers at Intermountain Medical Center and his team has found a cure for this deadly disease. An oral treatment routine made up of particular medicines that offers high success rate of curing hepatitis C virus infection after the treatment. The results of this research led by Dr. Charlton and his research team was published in the New England Journal of Medicine.

According to the researchers, this new cure includes an oral treatment regimen that will be administered to the patients. The scientists conducting the research said that the new treatment is far more successful than the older treatment methods. The results have been described as highly promising by Dr. Charlton and his team. He added that while the study was in progress, the researchers noticed that the liver functions improved for the maximum patients who participated in the research. The liver also stabilized after the treatment, reported the Hoops News                                          

"Although longer follow-up is needed, the ability to achieve a high cure rate of hepatitis C in patients with advanced liver disease - and the observation of early stabilization and improvement of liver function - raises the possibility of decreasing the number of patients with hepatitis C who need liver transplantation." Currently, liver failure is the largest cause of liver transplant in Europe and United States, as per CBC News.